Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis

J.R. Berger, D. Centonze, G. Comi, C. Confavreux, G. Cutter, G. Giovannoni, R. Gold, H.P. Hartung, F. Lublin, A. Miravalle, X. Montalban, P. O'Connor, T. Olsson, C.H. Polman, O. Stuve, J.S. Wolinsky, T. Ziemssen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)409-411
JournalAnnals of Neurology
Issue number3
Publication statusPublished - 2010

Cite this